WO2011053007A3 - 위릉채 추출물을 포함하는 모공 축소 또는 피지 분비 억제용 조성물 - Google Patents
위릉채 추출물을 포함하는 모공 축소 또는 피지 분비 억제용 조성물 Download PDFInfo
- Publication number
- WO2011053007A3 WO2011053007A3 PCT/KR2010/007465 KR2010007465W WO2011053007A3 WO 2011053007 A3 WO2011053007 A3 WO 2011053007A3 KR 2010007465 W KR2010007465 W KR 2010007465W WO 2011053007 A3 WO2011053007 A3 WO 2011053007A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition
- sebum secretion
- chinensis extract
- potentilla chinensis
- pore shrinkage
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/008—Preparations for oily skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/75—Anti-irritant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Birds (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
본 발명은 위릉채 추출물을 유효 성분으로 포함하는 모공 축소 또는 피지 분비 억제용 조성물에 관한 것이다. 본 발명에 따른 조성물에 포함되는 유효 성분인 위릉채 추출물은 SNARE(soluble N-ethylmaleimide-sensitive factor attachment protein receptor)의 복합체 형성을 저해하고, 신경전달물질의 배출을 저해할 수 있음이 확인되었는 바, 모공 축소 또는 피지 분비 억제용 조성물의 유효 성분으로 적합하게 사용될 수 있다.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090104415A KR101273066B1 (ko) | 2009-10-30 | 2009-10-30 | 위릉채 추출물을 포함하는 모공 축소 또는 피지 분비 억제용 조성물 |
KR10-2009-0104415 | 2009-10-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2011053007A2 WO2011053007A2 (ko) | 2011-05-05 |
WO2011053007A3 true WO2011053007A3 (ko) | 2011-09-29 |
Family
ID=43922838
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2010/007465 WO2011053007A2 (ko) | 2009-10-30 | 2010-10-28 | 위릉채 추출물을 포함하는 모공 축소 또는 피지 분비 억제용 조성물 |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR101273066B1 (ko) |
WO (1) | WO2011053007A2 (ko) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107714577A (zh) * | 2017-09-30 | 2018-02-23 | 朱耀灯 | 一种收缩毛孔精华液 |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20130109330A (ko) | 2012-03-27 | 2013-10-08 | 엘지이노텍 주식회사 | 태양전지 및 이의 제조 방법 |
KR102249700B1 (ko) | 2014-04-24 | 2021-05-10 | (주)아모레퍼시픽 | 박하초를 함유하는 화장료 조성물 |
KR101997474B1 (ko) * | 2016-06-13 | 2019-07-09 | 기초과학연구원 | 쿠커비투[n]릴을 이용하여 신경전달물질을 제어하는 방법 및 이의 용도 |
KR102110081B1 (ko) | 2019-07-29 | 2020-05-22 | (주)이시스코스메틱 | 복합 효소를 이용한 혼합 추출물을 함유하는 모공 수축 및 항산화용 화장료 조성물 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020029182A (ko) * | 2000-10-12 | 2002-04-18 | 성재갑 | 여로 추출물, 위릉채 추출물에서 선택되는 1종 이상을유효성분으로 함유하는 화장료 조성물 |
KR20030005381A (ko) * | 2000-05-26 | 2003-01-17 | 가부시키가이샤 시세이도 | 피지 분비 억제용 피부 외용약 |
KR20090041370A (ko) * | 2009-03-23 | 2009-04-28 | 성균관대학교산학협력단 | 꽃 추출물을 함유하는 snare 복합체 형성을 억제하기 위한 조성물 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004076634A2 (en) * | 2003-02-24 | 2004-09-10 | Ira Sanders | Cell membrane translocation of regulated snare inhibitors , compositions therefor, and methods for treatment of disease |
-
2009
- 2009-10-30 KR KR1020090104415A patent/KR101273066B1/ko active IP Right Grant
-
2010
- 2010-10-28 WO PCT/KR2010/007465 patent/WO2011053007A2/ko active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20030005381A (ko) * | 2000-05-26 | 2003-01-17 | 가부시키가이샤 시세이도 | 피지 분비 억제용 피부 외용약 |
KR20020029182A (ko) * | 2000-10-12 | 2002-04-18 | 성재갑 | 여로 추출물, 위릉채 추출물에서 선택되는 1종 이상을유효성분으로 함유하는 화장료 조성물 |
KR20090041370A (ko) * | 2009-03-23 | 2009-04-28 | 성균관대학교산학협력단 | 꽃 추출물을 함유하는 snare 복합체 형성을 억제하기 위한 조성물 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107714577A (zh) * | 2017-09-30 | 2018-02-23 | 朱耀灯 | 一种收缩毛孔精华液 |
Also Published As
Publication number | Publication date |
---|---|
WO2011053007A2 (ko) | 2011-05-05 |
KR20110047692A (ko) | 2011-05-09 |
KR101273066B1 (ko) | 2013-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2252274A1 (en) | Composition comprising a combination of omeprazole and lansoprazole, and a buffering agent, and methods of using same | |
WO2011053007A3 (ko) | 위릉채 추출물을 포함하는 모공 축소 또는 피지 분비 억제용 조성물 | |
ZA201202099B (en) | Polypeptides for binding to the "receptor for advanced glycation endproducts" as well as compositions and methods involving the same | |
WO2009078965A8 (en) | An improved process to prepare treprostinil, the active ingredient in remodulin® | |
WO2013130683A3 (en) | Xten conjugate compositions and methods of making same | |
WO2008157635A3 (en) | Synthetic bile acid composition, method, and preparation | |
MX2014001496A (es) | Composicion de liberacion sostenida de prostaciclina. | |
WO2011017502A3 (en) | Linaclotide-containing formulations for oral administration | |
SG10201805198TA (en) | 18f - fluciclovine compositions in citrate buffers | |
IL218130A (en) | Compounds containing pyrazole that are administered to bicyclo [0.1.3] hexane and pharmaceutical preparations containing them | |
GB201111609D0 (en) | Copolymers and membranes | |
WO2009104021A3 (en) | Novel polymorphs and processes for their preparation | |
EP2337834A4 (en) | ANTIOXIDANT COMPOSITION FOR MARINE OILS COMPRISING TOCOPHEROL, ROSEMARY EXTRACT, ASCORBIC ACID AND GREEN TEA EXTRACT | |
WO2011002179A3 (ko) | 복분자 추출물을 함유하는 피부 주름 개선용 화장료 조성물 | |
WO2010049449A3 (en) | Novel salts of sunitinib | |
WO2012021133A9 (en) | Synthetic bile acid compositions and methods | |
WO2011051968A3 (en) | Pharmaceutical compositions of lanthanum carbonate and process for the preparation thereof | |
WO2012002782A3 (ko) | 닥나무의 꽃과 열매 추출물을 함유하는 피부 미백용 피부 외용제 조성물 | |
WO2010148180A3 (en) | Cosmetic compositions and methods for enhanced uv protection | |
WO2013093465A3 (en) | Formulations | |
IL210279A0 (en) | Extended release compositions for high solubility, high permeability acdtive pharmaceutical ingredients | |
WO2010006904A3 (en) | Crystalline forms of rabeprazole sodium | |
WO2011148209A3 (en) | Use of diatomaceous earth in the pharmaceutical industry | |
MX339361B (es) | Derivados de alternano. | |
WO2010147441A3 (ko) | 밤껍질 추출물을 포함하는 화장료 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10827091 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 10827091 Country of ref document: EP Kind code of ref document: A2 |